Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US court narrows rules for judging patent disputes:

This article was originally published in Clinica

Executive Summary

In a ruling that impinges on the medical device industry, the US Federal Appeals Court has said that state adjudication in intellectual property matters cannot rely on common law standards such as fraud, but can only be judged by US patent law. The US Court of Appeals for the Federal Circuit reversed a $45 million decision against American Cyanamid last week which was based on claims of fraudulent non-disclosure and unjust enrichment alleged by two doctors from the University of Colorado.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT080093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel